English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 856852      Online Users : 938
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    圖書 [1/1]
    會議論文/會議摘要 [115/179]

    Collection Statistics

    近3年內發表的文件:58(17.58%)
    含全文筆數:327(99.09%)

    文件下載次數統計
    下載大於0次:327(100.00%)
    下載大於100次:311(95.11%)
    檔案下載總次數:137594(77.78%)

    最後更新時間: 2024-11-28 12:19


    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 151-200 of 330. (7 Page(s) Totally)
    << < 1 2 3 4 5 6 7 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2017-09 A phase II study of Arginine Deiminase (ADI-PEG20) in relapsed/refractory or poor-risk acute myeloid leukemia patients Scientific Reports. 2017 Sep;7:Article number 11253.
    2017-08 Overexpressed fatty acid synthase in gastrointestinal stromal tumors: Targeting a progression-associated metabolic driver enhances the antitumor effect of imatinib Clinical Cancer Research. 2017 Aug;23(16):4908-4918.
    2017-08 A randomized phase II study of gemcitabine plus Z-360, a CCK2 receptor-selective antagonist, in patients with metastatic pancreatic cancer as compared with gemcitabine plus placebo Cancer Chemotherapy and Pharmacology. 2017 Aug;80(2):307-315.
    2017-07 A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17 Oncotarget. 2017 Jul;8(27):44121-44130.
    2017-05 Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: A Q-TWiST analysis British Journal of Cancer. 2017 May;116(10):1247-1253.
    2017-05 A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 2531.
    2017-02 Nanoliposomal irinotecan in the clinical practice guideline for metastatic pancreatic cancer: Applicability to clinical situations Journal of Clinical Oncology. 2017 Feb;35(6):689-690.
    2017-02 The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21) Journal of Pathology. 2017 Feb;241(3):420-433.
    2017-02 Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells Oncology Reports. 2017 Feb;37(2):969-978.
    2017-01 Expressions of the CagA protein and CagA-signaling molecules predict H. pylori-dependence of early-stage gastric DLBCL Blood. 2017 Jan;129(2):188-198.
    2016-12 The efficacy and safety of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan Asia-Pacific Journal of Clinical Oncology. 2016 Dec;12(4):396-402.
    2016-11-21 A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors BMC Cancer. 2016 Nov 21;16:Article number 907.
    2016-10 Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor Cancer Research and Treatment. 2016 Oct;48(4):1155-1166.
    2016-10 BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia Molecular Cancer Therapeutics. 2016 Oct;15(10):2323-2333.
    2016-09 The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer Oncotarget. 2016 Sep;7(38):61136-61151.
    2016-08 Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma Journal of Hepatology. 2016 Aug;65(2):296-304.
    2016-07 Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer Expert Opinion on Pharmacotherapy. 2016 Jul;17(10):1413-1420.
    2016-05-14 Nanoliposomal irinotecan in metastatic pancreatic cancer - Authors' reply Lancet. 2016 May 14-20;387(10032):1997.
    2016-05-03 Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer Scientific Reports. 2016 May 3;6:Article number 25369.
    2016-05 Overexpression of regulator of G protein signaling 11 promotes cell migration and associates with advanced stages and aggressiveness of lung adenocarcinoma Oncotarget. 2016 May;7(21):31122-31136.
    2016-05 Efficacy of frontline antibiotics therapy in the treatment of Helicobacter pylori-negative gastric low-grade mucosa-associated lymphoid tissue lymphoma Journal of Clinical Oncology. 2016 May;34(15, Suppl. S):Abstract number e19024.
    2016-03 miR-520h is crucial for DAPK2 regulation and breast cancer progression Oncogene. 2016 Mar 3;35(9):1134-1142.
    2016-03 Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer Oncogene. 2016 May;35(12):1517-1528.
    2016-02 Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): A global, randomised, open-label, phase 3 trial Lancet. 2016 Feb;387(10018):545-557.
    2016-02 Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells RNA. 2016 Feb;22(2):303-315.
    2016-01 Investigating the association between periodontal disease and risk of pancreatic cancer Pancreas. 2016 Jan;45(1):134-141.
    2016-01 S-1 with leucovorin for gastric cancer: How far can it go? Lancet Oncology. 2016 Jan;17(1):12-14.
    2016-01 A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial Medicine. 2016 Jan;95(3):Article number e2565.
    2015-12-21 G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation Scientific Reports. 2015 Dec 21;5:Article number 18709.
    2015-10 Epigenetic regulation in the carcinogenesis of cholangiocarcinoma International Journal of Biochemistry and Cell Biology. 2015 Oct;67:110-114.
    2015-10 Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells Cancer Cell International. 2015 Oct;15:Article number 98.
    2015-09 AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-kappaB activation Leukemia and Lymphoma. 2015 Sep;56(9):2674-2682.
    2015-08 Primary gastrointestinal stromal tumor of the liver in an anorectal melanoma survivor: A case report Oncology Letters. 2015 Aug;10(4):2366-2370.
    2015-07 Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review Cancer Research and Treatment. 2015 Jul;47(3):343-361.
    2015-06 Helicobacter pylori CagA translocation is closely associated with the expression of CagA-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma American Journal of Surgical Pathology. 2015 Jun;39(6):761-766.
    2015-06 Comprehensive analysis of the incidence and survival patterns of lung cancer by histologies, including rare subtypes, in the era of molecular medicine and targeted therapy: A nation-wide cancer registry-based study from Taiwan Medicine. 2015 Jun;94(24):Article number e969.
    2015-05 A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer Annals of Oncology. 2015 May;26(5):943-949.
    2015-04-13 Association of dialysis with the risks of cancers PLoS ONE. 2015 Apr 13;10(4):Article number e0122856.
    2015-04 Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide Hepatology International. 2015 Apr;9(2):258-268.
    2015-04 The potent activation of Ca2+-activated K+ current by NVP-AUY922 in the human pancreatic duct cell line (PANC-1) possibly independent of heat shock protein 90 inhibition Journal of Pharmacological Sciences. 2015 Apr;127(4):404-413.
    2015-03 Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients Cancer Chemotherapy and Pharmacology. 2015 Mar;75(3):579-586.
    2015-03 Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1 Oncotarget. 2015 Mar;6(9):6684-6707.
    2014-12-01 AMACR amplification in myxofibrosarcomas: A mechanism of overexpression that promotes cell proliferation with therapeutic relevance Clinical Cancer Research. 2014 Dec 01;20(23):6141-6152.
    2014-11-30 MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors Oncotarget. 2014 Nov 30;5(22):11723-11736.
    2014-11 Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance Oncotarget. 2014 Nov 30;5(22):11428-11441.
    2014-10-18 AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: A driver of cell proliferation indicating adverse prognosis Oncotarget. 2014 Oct 18;5(22):11551-11566.
    2014-10-10 Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma Blood Cancer Journal. 2014 Oct 10;4:Article number eXX.
    2014-10 Stimulation of electroporation-induced inward currents in glioblastoma cell lines by the heat shock protein inhibitor AUY922 Clinical and Experimental Pharmacology and Physiology. 2014 Oct;41(10):830-837.
    2014-09 High effectiveness of triptolide, an active diterpenoid triepoxide, in suppressing Kir-channel currents from human glioma cells European Journal of Pharmacology. 2014 Sep;738:332-341.
    2014-09 Adaptation of international guidelines for metastatic colorectal cancer: An Asian consensus Clinical Colorectal Cancer. 2014 Sep;13(3):145-155.

    Showing items 151-200 of 330. (7 Page(s) Totally)
    << < 1 2 3 4 5 6 7 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback